Market Value988,380,000
Total Holdings57
File Date2015-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ISEE / IVERIC bio Inc
BBI / Brickell Biotech Inc
ARAV / Aravive, Inc.
AGIO / Agios Pharmaceuticals, Inc.
TXMD / TherapeuticsMD, Inc.
DYAX / Dyax Corp.
RMTI / Rockwell Medical, Inc.
DVAX / Dynavax Technologies Corporation
BLCM / Bellicum Pharmaceuticals, Inc.
OCRX / Ocera Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
RGLS / Regulus Therapeutics Inc.
NVAX / Novavax, Inc.
XNCR / Xencor, Inc.
OMER / Omeros Corporation
TGTX / TG Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc. Call
MACK / Merrimack Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
AKBA / Akebia Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
ALKS / Alkermes plc
ABUS / Arbutus Biopharma Corporation
TENX / Tenax Therapeutics, Inc.
RGEN / Repligen Corporation
SCMP / Sucampo Pharmaceuticals, Inc.
TROV / TrovaGene, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
PBYI / Puma Biotechnology, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
ZSPH / ZS Pharma, Inc.
JUNO / Juno Therapeutics, Inc.
CASC / Cascadian Therapeutics, Inc.
/ Array BioPharma, Inc.
SGMO / Sangamo Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
TTOO / T2 Biosystems, Inc.
AMGN / Amgen Inc.
ACAD / ACADIA Pharmaceuticals Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
H03579101 / Auris Medical Holding Ltd
FWP / Forward Pharma A/S - ADR
KYTH / Kythera Biopharma
CTIC / CTI BioPharma Corp
OREX / Orexigen Therapeutics, Inc.
KERX / Keryx Biopharmaceuticals, Inc.
TRVN / Trevena, Inc.
PTCT / PTC Therapeutics, Inc.
TSRO / TESARO, Inc.
WGBS / WaferGen Bio-Systems, Inc.
AGRX / Agile Therapeutics, Inc.
DRNA / Dicerna Pharmaceuticals Inc
BIIB / Biogen Inc.
ACAD / ACADIA Pharmaceuticals Inc. Call
LUMO / Lumos Pharma, Inc.
VXRT / Vaxart, Inc.
CELG / Celgene Corp.
AUPH / Aurinia Pharmaceuticals Inc.
TARA / Protara Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
LRMR / Larimar Therapeutics, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc. Call